Cargando…
Lumican – Derived Peptides Inhibit Melanoma Cell Growth and Migration
Lumican, a small leucine-rich proteoglycan of the extracellular matrix, presents potent anti-tumor properties. Previous works from our group showed that lumican inhibited melanoma cell migration and tumor growth in vitro and in vivo. Melanoma cells adhered to lumican, resulting in a remodeling of th...
Autores principales: | Pietraszek, Katarzyna, Brézillon, Stéphane, Perreau, Corinne, Malicka-Błaszkiewicz, Maria, Maquart, François-Xavier, Wegrowski, Yanusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788744/ https://www.ncbi.nlm.nih.gov/pubmed/24098450 http://dx.doi.org/10.1371/journal.pone.0076232 |
Ejemplares similares
-
Effect of Lumican on the Migration of Human Mesenchymal Stem Cells and Endothelial Progenitor Cells: Involvement of Matrix Metalloproteinase-14
por: Malinowski, Mariusz, et al.
Publicado: (2012) -
Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity
por: Stasiak, Marta, et al.
Publicado: (2016) -
Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition
por: Karamanou, Konstantina, et al.
Publicado: (2017) -
Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach
por: Dauvé, Jonathan, et al.
Publicado: (2021) -
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
por: Jeanne, Albin, et al.
Publicado: (2017)